Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Immune and hemorheological changes in chronic fatigue syndrome.

Brenu EW, Staines DR, Baskurt OK, Ashton KJ, Ramos SB, Christy RM, Marshall-Gradisnik SM.

J Transl Med. 2010 Jan 11;8:1. doi: 10.1186/1479-5876-8-1.

3.

Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.

Huth TK, Brenu EW, Ramos S, Nguyen T, Broadley S, Staines D, Marshall-Gradisnik S.

Scand J Immunol. 2016 Jan;83(1):44-51. doi: 10.1111/sji.12388.

4.

Immunological abnormalities in patients with chronic fatigue syndrome.

Tirelli U, Marotta G, Improta S, Pinto A.

Scand J Immunol. 1994 Dec;40(6):601-8.

PMID:
7997849
5.

Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).

Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Wong N, Ramos S, Staines D, Marshall-Gradisnik S.

BMC Immunol. 2015 Jun 2;16:35. doi: 10.1186/s12865-015-0101-4.

6.

The open window of susceptibility to infection after acute exercise in healthy young male elite athletes.

Kakanis MW, Peake J, Brenu EW, Simmonds M, Gray B, Hooper SL, Marshall-Gradisnik SM.

Exerc Immunol Rev. 2010;16:119-37.

7.

Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels.

Nguyen T, Johnston S, Clarke L, Smith P, Staines D, Marshall-Gradisnik S.

Clin Exp Immunol. 2017 Feb;187(2):284-293. doi: 10.1111/cei.12882. Epub 2016 Nov 23.

8.
9.

Immunologic abnormalities associated with chronic fatigue syndrome.

Barker E, Fujimura SF, Fadem MB, Landay AL, Levy JA.

Clin Infect Dis. 1994 Jan;18 Suppl 1:S136-41.

PMID:
8148441
10.

Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.

Brenu EW, Huth TK, Hardcastle SL, Fuller K, Kaur M, Johnston S, Ramos SB, Staines DR, Marshall-Gradisnik SM.

Int Immunol. 2014 Apr;26(4):233-42. doi: 10.1093/intimm/dxt068. Epub 2013 Dec 16.

PMID:
24343819
11.

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, Klimas NG, Marshall-Gradisnik SM.

J Transl Med. 2011 May 28;9:81. doi: 10.1186/1479-5876-9-81.

12.

Dysfunction of natural killer activity in a family with chronic fatigue syndrome.

Levine PH, Whiteside TL, Friberg D, Bryant J, Colclough G, Herberman RB.

Clin Immunol Immunopathol. 1998 Jul;88(1):96-104.

PMID:
9683556
13.

Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.

Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Ramos S, Staines D, Marshall-Gradisnik S.

J Transl Med. 2015 Sep 14;13:299. doi: 10.1186/s12967-015-0653-3.

14.

CD16- CD56+ natural killer cells after bone marrow transplantation.

Jacobs R, Stoll M, Stratmann G, Leo R, Link H, Schmidt RE.

Blood. 1992 Jun 15;79(12):3239-44.

15.

Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.

Tarazona R, Casado JG, Delarosa O, Torre-Cisneros J, Villanueva JL, Sanchez B, Galiani MD, Gonzalez R, Solana R, Peña J.

J Clin Immunol. 2002 May;22(3):176-83.

PMID:
12078859
16.
17.

Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.

Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, Tajouri L, Peterson D, Ramos SB, Marshall-Gradisnik SM.

J Transl Med. 2012 May 9;10:88. doi: 10.1186/1479-5876-10-88.

18.

Decreased nitric oxide-mediated natural killer cell activation in chronic fatigue syndrome.

Ogawa M, Nishiura T, Yoshimura M, Horikawa Y, Yoshida H, Okajima Y, Matsumura I, Ishikawa J, Nakao H, Tomiyama Y, Kanayama Y, Kanakura Y, Matsuzawa Y.

Eur J Clin Invest. 1998 Nov;28(11):937-43.

PMID:
9824439
19.

Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.

Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J, Garcia-Quintana AM, Castro-Marrero J, Negredo E, Clotet B, Cabrera C, Blanco J.

J Transl Med. 2013 Mar 20;11:68. doi: 10.1186/1479-5876-11-68.

20.

H₂O₂ production within tumor microenvironment inversely correlated with infiltration of CD56(dim) NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction.

Izawa S, Kono K, Mimura K, Kawaguchi Y, Watanabe M, Maruyama T, Fujii H.

Cancer Immunol Immunother. 2011 Dec;60(12):1801-10. doi: 10.1007/s00262-011-1082-7. Epub 2011 Aug 3.

PMID:
21811786

Supplemental Content

Support Center